Event
Singapore Life Sciences Roundtable
Wednesday, September 3, 2025
This intimate, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical, medtech, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific.
Topics include:
- The New DOJ White Collar Enforcement Playbook
What it means for APAC operations and compliance functions - The New U.S. Administration and the FDA
Taking stock of paradigm-shifting developments in drug and device regulation - Life Sciences Transactions in APAC
Navigating deal risks, regulatory scrutiny, and cross-border trends
PROGRAM
Registration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT
Sidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT
Networking Lunch: 12:00 p.m. – 1:00 p.m. SGT
For questions or more information, please contact asiaevents@sidley.com.
Contacts
Offices
Capabilities
Suggested News & Insights
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


